Perioperative management of patients with neuromuscular disease (project of FAR clinical guidelines)

Abstract

The project of clinical guidelines proposed by Federation of anesthesiologists of Russia is dedicated to questions of perioperative management of patients suffering from neuromuscular diseases and other pathological conditions and disorders that involved interaction between neural and striated muscular systems.

Keywords

perioperative management of patient / neuromuscular disease

References

[1] Лебединский К. М., Триадский А. А., Оболенский С. В. Злокачественная гипертермия: фармакогенетически обусловленный острый массивный рабдомиолиз. Анестезиология и реаниматология. 2008; 4: 66-70.

[2] Неврология: национальное руководство / под ред. Е. И. Гусева, А. Н. Коновалова, В. И. Скворцовой, А. Б. Гехт. М.: ГЕОТАР-Медиа, 2009. 1040 с. (Серия «Национальные руководства»).

[3] Яхно Н. Н., Штульман Д. P Болезни нервной системы. Медицина; 2005.

[4] Anema J. R., Heijenbrok M. W., Faes T. J. et al. Cardiovascular autonomic function in multiple sclerosis. J Neurol Sci. 1991; 104: 129-134.

[5] Badr A. E., Mychaskiw G. 2nd, Eichhorn J. H. Metabolic acidosis associated with a new formulation of propofol. Anesthesiology. 2001; 94: 536-538.

[6] Baraka A. Onset of neuromuscular block in myasthenic patients. Br J Anaesth. 1992; 69: 227-228.

[7] Baraka A. Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase. Anaesthesia. 1992; 47: 217-219.

[8] Baur C. P., Schlecht R., Jurkat-Rott K., Georgieff M., Lehmann-Horn F. Anesthesia in neuromuscular disorders. Part 1: introduction. Anasthesiol Intensivmed Notfallmed Schmerzther. 2002; 37(2): 77-83.

[9] Baur C. P., Schara U., Schlecht R., Georgieff M., Lehmann-Horn F. Anesthesia in neuromuscular disorders. Part 2: specific disorders. Anasthesiol Intensivmed Notfallmed Schmer-zther. 2002; 37(3): 125-137.

[10] Birnkrant D. J., Panitch H. B., Benditt J. O., Boitano L. J. et al. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest. 2007; 1977-1986.

[11] Beloiartsev A., Gableske S., Hübler M. Neuromuscular monitoring in patients with neuromuscular diseases. Options and needs. Anaesthesist. 2009 Jul; 58(7): 731-741.

[12] Brambrink A. M., Kirsch J. R. Perioperative care of patients with neuromuscular disease and dysfunction. Anesthesiol Clin. 2007 Sep; 25(3): 483-509.

[13] Breucking E., Mortier W. Anesthesia in neuromuscular diseases. Acta Anaesthesiol Belg. 1990; 127-132.

[14] Clay A. S., Behnia M., Brown K. K. Mitochondrial disease: A pulmonary and critical care medicine perspective. Chest. 2001; 120: 634-648.

[15] Dalakas M. C., Ilia I., Pezeshkpour G. H. et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990; 322: 1098-1105.

[16] DiMauro S., Bonilla E., Davidson M. et al: Mitochondria in neuromuscular disorders. Biochim Biophys Acta. 1998; 1366: 199-210.

[17] Durbeej M., Campbell K. P Muscular dystrophies involving the dystrophin-glycoprotein complex: An overview of current mouse models. Curr Opin Genet Dev. 2002; 12: 349-361.

[18] Eichhorn J. H., Cooper J. B., Cullen D. J. et al. Standarts of patient monitoring during anesthesia at Harvard Medical School. J Am Med Ass. 1986; 256: 1017-1020.

[19] Emery A. E. The muscular dystrophies. Lancet. 2002; 359: 687695.

[20] Flewellen E. H., Bodensteiner J. B. Anesthetic experience in a patient with hyperkalemic periodic paralysis. Anesth Rev. 1980; 7: 44.

[21] Fontaine B., Vale-Santos J., Jurkat-Rott K. et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome lq31-32 in three European families. Nat Genet. 1994; 6: 267-272.

[22] Genever E. E. Suxamethonium-induced cardiac arrest in unsuspected pseudohypertrophic muscular dystrophy. Case report. Br J Anaesth. 1971; 43: 984-986.

[23] Gurnaney H., Brown A., Litman R. S. Malignant hyperthermia and muscular dystrophies. Anesth Analg. 2009 Oct; 109(4): 1043-1048.

[24] Harper P. S. Myotonic Dystrophy, 3rd ed. London, WBSaunders, 2001.

[25] Hirsch N. P Neuromuscular junction in health and disease. Br J Anaesth. 2007; 99: 132-138.

[26] Howell N. Human mitochondrial diseases: Answering questions and questioning answers. Int Rev Cytol. 1999; 186: 49-116.

[27] Johannsen S., Kranke P, Reiners K., Schuster F. Perioperative management of patients with neuromuscular disorders. Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Nov; 44(11-12): 748-755.

[28] Juel V C., Bleck T P Neuromuscular disorders in the ICU. Fink M.P, Abraham E., Vincent J.-L., Kochanek PM. Textbook of Critical Care (5 eds.), 2005.

[29] Jurkat-Rott K., Lerche H., Lehmann-Horn F. Skeletal muscle channelopathies. J Neurol. 2002; 249: 1493-1502.

[30] Laghi F., Tobin M. J. Disorders of the respiratory muscles. American Journal Of Respiratory And Critical Care Medicine. 2003; 168.

[31] Lee D., Lee K. C., Kim J. Y., Park Y. S., Chang Y. J. Total intravenous anesthesia without muscle relaxant in a patient with amyotrophic lateral sclerosis. J Anesth. 2008; 22(4): 443-445.

[32] Maslow A., Lisbon A. Anesthetic considerations in patients with mitochondrial dysfunction. Anesth Analg. 1993; 76: 884-886.

[33] Naguib M., Lien C. A. Pharmacology of muscle relaxants and their antagonists. In Miller RD (ed): Miller's Anesthesia, 6th ed. New York, Churchill Livingstone. 2005; 481-572.

[34] Parke T J., Stevens J. E., Rice A. S. et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports. BMJ. 1992; 305: 613-616.

[35] Roland E. H. Muscular dystrophy. Pediatr Rev. 2000; 21: 233237.

[36] Rosenbaum K. J., Neigh J. L., Strobel G. E. Sensitivity to nondepolarizing muscle relaxants in amyotrophic lateral sclerosis: Report of two cases. Anesthesiology. 1971; 35: 638-641.

[37] Sanders D. B. Lambert-Eaton myasthenic syndrome: Clinical diagnosis, immune-mediated mechanisms, and update on therapies. Ann Neurol. 1995; 37(Suppl 1): S63-S73.

[38] Sasano N., Fujita Y., So M., Sobue K., Sasano H., Katsuya H. Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy. J Anesth. 2007; 21(1): 72-75.

[39] Shapiro F., Sethna N., Colan S. et al. Spinal fusion in Duchenne muscular dystrophy: A multidisciplinary approach. Muscle Nerve. 1992; 15: 604-614.

[40] Shiraishi M., Minami K., Kadaya T. A safe anesthetic method using caudal block and ketamine for the child with congenital myotonic dystrophy. Anesth Analg. 2002; 94: 233.

[41] Siler J. N., Discavage W J. Anesthetic management of hypokalemic periodic paralysis. Anesthesiology. 1975; 43: 489-490.

[42] Small S., Ali H. H., Lennon V. A. et al. Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma. Anesthesiology. 1992; 76: 142-145.

[43] Stevens R. D., Dowdy D. W., Michaels R. K. et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007 Nov; 33(11): 1876-1891.

[44] Tobar E., Bugedo G., Andresen M., Aguirre M. et al. Characteristics and impact of sedation, analgesia, and neuromuscular blockage in critical patients undergoing prolonged mechanical ventilation. Med Intensiva. 2009 Oct; 33(7): 311-320.

[45] Vassiliev D. V., Nystrom E. U., Leicht C. H. Combined spinal and epidural anesthesia for labor and cesarean delivery in a patient with Guillain-Barre syndrome. Reg Anesth Pain Med. 2001; 26: 174-176.

[46] Vincent A., Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry. 1985; 48: 1246-1252.

[47] Viscomi C. M., Ptacek L. J., Dudley D. Anesthetic management of familial hypokalemic periodic paralysis during parturition. Anesth Analg. 1999; 88: 1081-1082.

[48] Warren T. M., Datta S., Ostheimer G. W Lumbar epidural anesthesia in a patient with multiple sclerosis. Anesth Analg. 1982; 61: 1022-1023.

[49] Weller J. F., Elliott R. A., Pronovost P J. Spinal anesthesia for a patient with familial hyperkalemic periodic paralysis. Anesthesiology. 2002; 97: 259-260.

[50] Wright R. B. Myasthenia. In Klawans HL, Goetz CG, Tattler CM (eds): Textbook of Clinical Neuropharmacology and Therapeutics. New York, Raven Press. 1992; 505-516.

[51] Young C. C., Sladen R. N. Hyperthermia. In: Complications in Anesthesia, 2nd ed. J. L. Atlee (ed.) 2007; 423-426.

[52] Zeviani M., Amati P, Savoia A. Mitochondrial myopathies. Curr. Opin. Rheumatol. 1994; 6: 559-567.

[53] Zisfein J., Sivak M., Aron A. M. et al. Isaacs' syndrome with muscle hypertrophy reversed by phenytoin therapy. Arch Neurol. 1983; 40: 241-242.

[54] Zochodne D. W. Autonomic involvement in Guillain-Barre syndrome: A review. Muscle Nerve. 1994; 17: 1145-1155.

RIGHTS & PERMISSIONS

Eco-Vector